Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

AMenariniDiagnostics

More Like This

PR Newswire associated0

Pangea Laboratory Partners with Unilabs to Introduce Bladder CARE™ Assay in Switzerland, Advancing Non-Invasive Cancer Diagnostics Across Europe

PR Newswire associated0

/C O R R E C T I O N -- Menarini Silicon Biosystems/

European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care

Clinical data presentations at the European Association of Urology (EAU) 2025 congress highlight the benefits of using Blue Light Cystoscopy in bladder cancer

PR Newswire associated0

Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH

PR Newswire associated0

Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma

Antech’s breakthrough cancer screening tool launches in Europe, supporting early canine cancer detection

PR Newswire associated0

European Organisation for Research and Treatment of Cancer & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us